CONFIDENTIAL GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENTGalectin-3 License and Distribution Agreement • February 3rd, 2011 • BG Medicine, Inc. • Services-medical laboratories • Delaware
This GALECTIN -3 LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”), entered into as of December 14, 2010 (the “Effective Date”), by and between Siemens Healthcare Diagnostics Inc, a corporation of the state of California, having its principal place of business at 511 Benedict Avenue, Tarrytown, NY 10591 (“SIEMENS”) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610N Lincoln Street, Waltham, MA 02451 (“BGM”).
CONFIDENTIAL GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENTGalectin-3 License and Distribution Agreement • August 31st, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
This GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”), entered into as of November 11, 2009 (the “Effective Date”), by and between Abbott Laboratories, a corporation of the state of Illinois, having its principal place of business at 100 Abbott Park Road, Abbott Park, IL 60064-3500 (“Abbott”) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (“BGM”).
CONFIDENTIAL GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENTGalectin-3 License and Distribution Agreement • November 8th, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
This GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”), entered into as of May 29, 2010 (the “Effective Date”), by and between bioMérieux SA, a Société Anonyme (corporation) organized under the laws of France having its principal place of business at Chemin de l’Orme, 69280 Marcy l’Etoile, France (“BMX”). and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (“BGM”).
CONFIDENTIAL GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENTGalectin-3 License and Distribution Agreement • November 8th, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
This GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”), entered into as of March 19, 2010 (the “Effective Date”), by and between Inverness Medical Innovations, Inc., a corporation of the state of Delaware, having its principal place of business at 51 Sawyer Road, Suite 200, Waltham, MA 02453 (“IMI”) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (“BGM”).
